Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Lancaster Colony Corp. (LANC): Hedge Funds Are Bullish and Insiders Are Undecided, What Should You Do?

Page 1 of 2

Lancaster Colony Corp. (NASDAQ:LANC) investors: listen up.

In today’s marketplace, there are tons of methods shareholders can use to track Mr. Market. Two of the best are hedge fund and insider trading interest. At Insider Monkey, our research analyses have shown that, historically, those who follow the top picks of the elite money managers can outpace the market by a superb margin (see just how much).

Just as useful, bullish insider trading sentiment is a second way to look at the marketplace. As the old adage goes: there are many incentives for a corporate insider to drop shares of his or her company, but just one, very clear reason why they would initiate a purchase. Many academic studies have demonstrated the impressive potential of this method if “monkeys” understand what to do (learn more here).

Lancaster Colony Corp. (NASDAQ:LANC)

Keeping this in mind, we’re going to examine the latest info for Lancaster Colony Corp. (NASDAQ:LANC).

How have hedgies been trading Lancaster Colony Corp. (NASDAQ:LANC)?

At the end of the second quarter, a total of 12 of the hedge funds we track were long in this stock, a change of 20% from the previous quarter. With hedge funds’ sentiment swirling, there exists a few notable hedge fund managers who were boosting their stakes considerably.

According to our 13F database, Chuck Royce’s Royce & Associates had the most valuable position in Lancaster Colony Corp. (NASDAQ:LANC), worth close to $88 million, accounting for 0.3% of its total 13F portfolio. Sitting at the No. 2 spot is Yacktman Asset Management, managed by Donald Yacktman, which held a $41.5 million position; 0.2% of its 13F portfolio is allocated to the stock. Other hedgies with similar optimism include Jim Simons’s Renaissance Technologies, Cliff Asness’s AQR Capital Management and Roger Keith Long’s Otter Creek Management.

With a general bullishness amongst the titans, particular hedge funds have been driving this bullishness. Royce & Associates, managed by Chuck Royce, initiated the most outsized position in Lancaster Colony Corp. (NASDAQ:LANC). Royce & Associates had 88 million invested in the company at the end of the quarter. Donald Yacktman’s Yacktman Asset Management also initiated a $41.5 million position during the quarter. The other funds with brand new LANC positions are Jim Simons’s Renaissance Technologies, Cliff Asness’s AQR Capital Management, and Roger Keith Long’s Otter Creek Management.

How are insiders trading Lancaster Colony Corp. (NASDAQ:LANC)?

Bullish insider trading is particularly usable when the company we’re looking at has experienced transactions within the past 180 days. Over the last half-year time period, Lancaster Colony Corp. (NASDAQ:LANC) has experienced zero unique insiders purchasing, and zero insider sales (see the details of insider trades here).

We’ll also examine the relationship between both of these indicators in other stocks similar to Lancaster Colony Corp. (NASDAQ:LANC). These stocks are Dole Food Company, Inc. (NYSE:DOLE), Cal-Maine Foods Inc (NASDAQ:CALM), Sanderson Farms, Inc. (NASDAQ:SAFM), Post Holdings Inc (NYSE:POST), and The WhiteWave Foods Co (NYSE:WWAV). This group of stocks are in the food – major diversified industry and their market caps resemble LANC’s market cap.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!